论文部分内容阅读
目的观察盐酸坦洛新联合前列安通片对慢性前列腺炎的临床疗效。方法随机选取我院2009年3月-2012年3月门诊及住院慢性前列腺炎患者40例,给予口服盐酸坦洛新和前列安通片治疗,观察治疗前后患者的疗效、慢性前列腺炎症积分指数(NIH-COSI评分)、前列腺液中白细胞(EPS-WBC)、卵磷脂小体的变化,以及自由尿流率、最大尿流率(MFR)、达到最大尿流率的时间(MT)、残余尿量的变化。结果盐酸坦洛新联合前列安通片对慢性前列腺炎的总有效率为92.5%。与治疗前比较,NIH-CPSI评分、前列腺液中白细胞、卵磷脂小体的变化均有明显的改变,差异有统计学意义(P<0.05);自由尿流率、最大尿流率(MFR)、达到最大尿流率的时间(MT)以及残余尿量也有明显改善,差异有统计学意义(P<0.05)。二者联合治疗期间患者无明显的药物不良反应。结论盐酸坦洛新联合前列安通片对慢性前列腺炎有较好的临床效果,药物不良反应少,值得推广应用。
Objective To observe the clinical efficacy of tamsulosin hydrochloride combined with Qianlie AnTong tablets on chronic prostatitis. Methods 40 cases of outpatients and inpatients with chronic prostatitis were randomly selected from March 2009 to March 2012 in our hospital. Oral administration of tamsulosin hydrochloride and Qianlie AnTong tablets was used to observe the curative effect of the patients before and after treatment. The scores of chronic prostatitis (NIH-COSI score), EPS-WBC and lecithin in the prostatic fluid, as well as the changes of free urine flow rate, maximum flow rate (MFR), time to maximum flow rate (MT), residual urine The amount of change. Results The total effective rate of tamsulosin hydrochloride combined with Qianlie AnTong tablets on chronic prostatitis was 92.5%. Compared with before treatment, NIH-CPSI score, leukocyte and lecithin in prostatic fluid had significant changes (P <0.05), free urine flow rate, maximum flow rate (MFR) , The time to reach the maximum urinary flow rate (MT) and residual urine volume also significantly improved, the difference was statistically significant (P <0.05). During the combined treatment of the two patients no obvious adverse drug reactions. Conclusion Tamsulosin hydrochloride combined with Qianlieantong tablets has better clinical effect on chronic prostatitis, less adverse drug reactions, which is worth popularizing and applying.